Skip to main content

Natera Inc(NTRA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low201.94
Day High207.79
Open:202.60
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
NTRA
StockStory
3 Reasons We’re Fans of Natera (NTRA)
NTRA
StockStory
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
NTRA
Tipranks
Barclays Sticks to Its Buy Rating for Natera (NTRA)
StockStory
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm
HLT
StockStory
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky
SPT
StockStory
3 Reasons NTRA Has Explosive Upside Potential
NTRA
Tipranks
Natera Expands Board, Appoints Eric Rubin as Director
StockStory
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
ELAN
StockStory
1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds
HNST
StockStory
1 Cash-Heavy Stock to Target This Week and 2 We Question
REAX
StockStory
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
NEO
Motley Fool
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment
Motley Fool
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock
StockStory
3 Growth Stocks to Add to Your Roster
TOST
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Natera (NTRA) and Nektar Therapeutics (NKTR)
StockStory
3 Market-Beating Stocks to Target This Week
BLBD
StockStory
3 Healthcare Stocks to Target This Week
NTRA
Tipranks
Natera Inc. Earnings Call Signals Profitable Growth
StockStory
Natera (NTRA) Stock Trades Up, Here Is Why
NTRA
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Jefferies Remains a Buy on Natera (NTRA)
Tipranks
Piper Sandler Keeps Their Buy Rating on Natera (NTRA)
Motley Fool
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade
StockStory
Why Natera (NTRA) Shares Are Falling Today
NTRA
Motley Fool
Natera (NTRA) Q4 2025 Earnings Call Transcript
StockStory
Natera Earnings: What To Look For From NTRA
NTRA
Motley Fool
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks
Tipranks
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), Centene (CNC) and Natera (NTRA)
Zacks Investment Research
EXEL Q4 Earnings and Revenues Beat, Colorectal Cancer Drug in Focus
EXEL Q4 Earnings and Revenues Beat, Colorectal Cancer Drug in Focus
Zacks Investment Research
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
StockStory
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
NTRA

Profile

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.